Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the brain.
Although measurements of GABA levels in vivo in the human brain using edited proton …

Abstract γ‐Aminobutyric acid (GABA) is the chief inhibitory neurotransmitter of the human
brain, and GABA‐ergic dysfunction has been implicated in a variety of neuropsychiatric …

A novel, two‐dimensional, J‐resolved chemical‐shift imaging sequence was used to collect
γ‐aminobutyric acid (GABA) spectroscopic imaging data on six healthy subjects at 4 T …

The objectives of this study were to examine the reproducibility of the MEGA‐editing J‐
difference technique and to determine the normal variation in the γ‐aminobutyric acid …

Purpose To determine whether there are in vivo differences of γ‐aminobutyric acid (GABA)
levels in frontal and parietal regions of Alzheimer's disease (AD) patients, compared with …

Background Gamma-aminobutyric acid (GABA), the brain's principal inhibitory
neurotransmitter, has been associated with perceptual and attentional functioning. Recent …

Purpose The conventional spectral‐editing experiment used to measure GABA in the human
brain also contains a contribution from macromolecules (MM), and the combined GABA plus …

γ-Aminobutyric acid (GABA) is the major inhibitory neurotransmitter in human brain and has
been implicated in several neuropsychiatric disorders. In vivo human brain GABA …

A quantitative method to assess in vivo brain gamma-aminobutyric acid (GABA) levels is
proposed using a J-resolved, two-dimensional (2D) magnetic resonance spectroscopy …

Short‐TE MRS has been proposed recently as a method for the in vivo detection and
quantification of γ‐aminobutyric acid (GABA) in the human brain at 3 T. In this study, we …